Internal Medicine, Pulmonary Disease · Deerfield Beach, FL
NPI
1245469923
Since 2009
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
6
Medicare group memberships
Hospitals
4
Hospital affiliations
1 W Sample Rd Ste 201
Deerfield Beach, FL, 33064
Phone (954) 876-2575
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
263 services
Medicare patients, 2024
128
Average age 71
Drug cost, 2024
$5.6M
542 prescriptions
Company payments, 2025
$95.88
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J de la Zerda was code 99291 (critical care e&m), 116 times for 49 patients. In total David J de la Zerda billed 263 services in 16 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 116 | 49 | $177.91 | $21K |
| 99232 Hospital E&M - Subsequent | Facility | 83 | 51 | $66.24 | $5,498 |
| 99212 Office E&M - Established | Facility | 30 | 19 | $29.98 | $899 |
By year: 2022 $37K for 311 services; 2023 $31K for 258 services; 2024 $29K for 263 services.
Medicare prescription drug claims, 2024
In 2024, the drug David J de la Zerda prescribed most often to Medicare patients was Opsumit (Macitentan), with 135 prescriptions and refills. In total David J de la Zerda wrote 542 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Opsumit Macitentan | 135 | 135 | 16 | $1.7M |
| Sildenafil Citrate Generic | 85 | 95 | Under 11 | $13K |
| Adempas Riociguat | 68 | 68 | Under 11 | $850K |
| Uptravi Selexipag | 63 | 63 | Under 11 | $1.6M |
| Tyvaso Dpi Treprostinil | 36 | 36 | Under 11 | $836K |
| Ambrisentan Generic | 33 | 33 | Under 11 | $92K |
| Letairis Ambrisentan | 27 | 27 | Under 11 | $343K |
| Furosemide Generic | 20 | 44 | Under 11 | $133 |
| Tadalafil Generic | 13 | 13 | Under 11 | $717 |
| Loperamide Loperamide Hcl | 11 | 11 | Under 11 | $47.98 |
| Revatio Sildenafil Citrate | 11 | 11 | Under 11 | $63K |
Brand drugs: 368 claims; generic drugs: 174 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J de la Zerda $95.88 ($95.88 in general payments such as food, travel and fees) from 3 companies. The largest payer was United Therapeutics Corporation with $46.08.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.